Healthcare

Pharmaceuticals Medical Devices Health Insurance Pharmaceutical Industry Healthcare Companies Biotechnology Insurance Medical Technology Healthcare Services Healthcare Providers

One-Week Deadline Nears for Telix Investors in Securities Class Action

The case centers on allegations tied to an SEC probe and an FDA rejection that preceded steep share losses.

Inspire Medical Faces Investor Class Actions as Lead Plaintiff Deadline Nears

SHINE Closes Lantheus SPECT Deal, Appoints Michael Rossi to Lead SHINE SPECT USA

Hagens Berman and Pomerantz Launch Probes Into Rezolute After Phase 3 Ersodetug Failure

Bristol Myers Enters 2026 With Eliquis Medicaid Pact, Opdivo Qvantig Rollout, and Divergent Analyst Views

FDA-Cleared Wegovy Pill Becomes First Oral GLP-1 for Weight Loss

Inspire Medical Faces Securities Class Action Over Inspire V Rollout as Lead‑Plaintiff Deadline Nears

Law Firms Urge Telix Investors Ahead of Lead‑Plaintiff Deadline in Securities Class Action

Inspire Medical Investors Face Jan. 5 Deadline in Suit Over Inspire V Rollout Claims

Zydus to Commercialize FDA-Approved Interchangeable Lucentis Biosimilar NUFYMCO in U.S. Under Bioeq Deal

FDA Approves Novo Nordisk’s Wegovy Pill, First Oral GLP-1

Inspire Medical Investors Face Jan. 5 Deadline in Lawsuits Over Troubled Inspire V Rollout

Skye Bioscience Investors Face Jan. 16 Lead-Plaintiff Deadline in Lawsuit Over Nimacimab Claims

Cramer Praises Medline’s Strong IPO Debut but Urges Patience on Price

Inspire Medical Investors Face Jan. 5 Lead-Plaintiff Deadline in Securities Suit Over Inspire V Rollout

Medtronic’s Diabetes Unit MiniMed Files for Nasdaq IPO

Jan. 16 Deadline Nears in Skye Bioscience Investor Class Actions

Medline Closes Upsized IPO After Soaring Debut in 2025’s Largest Listing

Trump Poised to Launch Medicare CBD Pilot as Early as 2026

GreensKeeper’s Value Fund Edges Positive for 2025 After 4% Q3 Lift